A previous study showed that an OV expressing hPD-1scFv could safely and effectively enhance systemic anti-tumor immunity by boosting T cells and overcoming local immunosuppression to make tumors more responsive to CTLA-4 or TIM-3 blockade.130. This evidence concerns the gene CTLA4 and neoplasm.